CAC
IMUC

Certified Advisory Corp’s ImmunoCellular Therapeutics, Ltd. IMUC Stock Holding History

Certified Advisory Corp’s Portfolio IMUC Stock Details IMUC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-20
Closed – – 795
2018
Q4 		$0 Hold
20
– – ﹤0.01% 822
2018
Q3 		$0 Hold
20
– – ﹤0.01% 835
2018
Q2 		$0 Hold
20
– – ﹤0.01% 824
2018
Q1 		$0 Hold
20
– – ﹤0.01% 818
2017
Q4 		$0 Buy
+20
New +$7 ﹤0.01% 731

Certified Advisory Corp's IMUC Position: Q1 2019 in Review

Certified Advisory Corp sold out of ImmunoCellular Therapeutics, Ltd. (IMUC) in Q1 2019, closing a stake of 20 shares.

Certified Advisory Corp first reported a position in IMUC in Q4 2017 and held it in 5 quarters. The position peaked at $0 in Q4 2018. 1 fund tracked by Wall St. Rank holds IMUC as of Q1 2019.

  • Certified Advisory Corp reported no remaining ImmunoCellular Therapeutics, Ltd. position as of Q1 2019 after selling out during the quarter.
  • Certified Advisory Corp sold 20 ImmunoCellular Therapeutics, Ltd. shares in Q1 2019.
  • Certified Advisory Corp first reported a position in ImmunoCellular Therapeutics, Ltd. in Q4 2017 and held it in 5 quarters.
  • Certified Advisory Corp's ImmunoCellular Therapeutics, Ltd. position peaked at $0 in Q4 2018.
  • 1 fund tracked by Wall St. Rank held ImmunoCellular Therapeutics, Ltd. as of Q1 2019.

Based on Certified Advisory Corp's 13F filing for Q1 2019, filed 7 May 2019.